Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2025 Earnings Call Transcript August 7, 2025
Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.11.
Operator: Good afternoon. My name is Latanya, and I will be your conference call operator today. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conference over to your host today, Mariann Ohanesian, Senior Director of IR for Puma Biotechnology. You may...
